The Congressional Budget Office on Friday said that Senate Democrats’ proposal to allow Medicare to negotiate certain drug prices could lower the federal deficit by about $288 billion through 2031, and reduce drugmakers’ 1,300 total drug approvals by about 10 drugs over the next three decades.